Spero Therapeutics Inc.

SPRO | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.33

+$0.19 (+16.67%)

Sep 22, 2026, 1:47 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	59.62M	47.98M	103.78M	48.58M	3.07M	9.33M
Cost of Revenue	n/a	96.76M	51.44M	n/a	n/a	67M
Gross Profit	59.62M	-48.78M	52.34M	48.58M	3.07M	-57.67M
Operating Income	-24K	-73.36M	21.48M	-42.2M	-87.97M	-79.11M
Interest Income	2.51M	4.74M	3.94M	1.11M	346K	401K
Pretax Income	8.83M	-68.57M	25.4M	-46.42M	-89.76M	-78.28M
Net Income	8.57M	-68.57M	22.81M	-46.42M	-89.76M	-78.28M
Selling & General & Admin	21.18M	23.7M	25.55M	36.48M	41.7M	21.44M
Research & Development	38.47M	96.76M	51.44M	47.59M	64.53M	69.4M
Other Expenses	n/a	-95.88M	-46.13M	6.7M	-15.19M	-69.4M
Operating Expenses	59.64M	24.58M	30.86M	90.78M	91.04M	21.44M
Interest Expense	n/a	n/a	n/a	2.61M	1.94M	n/a
Selling & Marketing Expenses	n/a	792K	566K	n/a	n/a	476K
Cost & Expenses	59.64M	121.34M	82.3M	90.78M	91.04M	88.44M
Income Tax Expense	261K	n/a	2.6M	n/a	n/a	n/a
Shares Outstanding (Basic)	56.02M	54.04M	52.7M	37.59M	30.9M	22.39M
Shares Outstanding (Diluted)	59.04M	54.04M	52.99M	37.59M	30.9M	22.39M
EPS (Basic)	0.15	-1.27	0.43	-1.23	-2.91	-3.52
EPS (Diluted)	0.15	-1.27	0.43	-1.23	-2.91	-3.52
EBITDA	8.83M	-72.48M	27.15M	-42.94M	-87.17M	-78.35M
EBIT	8.83M	-72.48M	26.79M	-43.81M	-87.82M	-79.11M
Depreciation & Amortization	n/a	2K	367K	869K	646K	761K